Table 5 Faecal calprotectin levels in different stages of colorectal cancer
Author | Year | CRC total n | Stage | Comment | |||
|---|---|---|---|---|---|---|---|
0/I | II | III | IV | ||||
n (%) | n (%) | n (%) | n (%) | ||||
FC (Median) | FC (Median) | FC (Median) | FC (Median) | ||||
Gilbert | 1996 | 14 | Â | 5 (36.0) | 2 (14.0) | 7 (50.0) | Stage had no effect on faecal calprotectin levels |
Kristinsson | 1998 | 119 | 25 (21.0) | 33 (28.0) | 36 (30.0) | 25 (21.0) | No significant difference |
| Â | Â | Â | 50Â mg/l | 65Â mg/l | 34Â mg/l | 38Â mg/l | Â |
Kristinsson | 2001 | 155 | 20 (13.0) | 66 (43.0) | 45 (29.0) | 23 (15.0) | No significant difference |
| Â | Â | Â | 27Â mg/l | 49Â mg/l | 42Â mg/l | 48Â mg/l | Â |
Tibble | 2001 | 62 | 10 (16.0) | 24 (39.0) | 14 (23.0) | 14 (23.0) | No significant difference (p > 0.2) |
| Â | Â | Â | 62.5Â mg/l | 115Â mg/l | 62Â mg/l | 132Â mg/l | Â |
Karl | 2008 | 85 (186) | 23 (27.0) | 27 (32.0) | 12 (14.0) | 23 (27.0) | 85/186 CRC had stage specified |
|  |  |  | 179.2 μg/g | 550.2 μg/g | 542.5 μg/g | 312.8 μg/g |  |
Kalimutho | 2011 | 28 | 7 | 5 | 3 | Â | 18 CRC either did not have FC or stage data |
| Â | Â | Â | 4/7+ve FC | 3/5+ve FC | 3/3+ve FC | Â | Â |
Lehman | 2014 | 80 |  |  |  |  | Patients with T3/4 disease had significantly higher FC than T1/2 (p = 0.022) |